| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 0 | 0 | 0 | 45.262 |
| Total Income - EUR | - | - | - | - | - | - | 0 | 13 | 29.733 | 47.546 |
| Total Expenses - EUR | - | - | - | - | - | - | 697 | 4.914 | 73.220 | 251.573 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | -697 | -4.901 | -43.487 | -204.027 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | -697 | -4.902 | -43.487 | -204.027 |
| Employees | - | - | - | - | - | - | 0 | 0 | 2 | 4 |
Check the financial reports for the company - Medisprof Cancer Center Moldova S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 160.432 | 323.827 | 1.084.418 | 1.224.498 |
| Current Assets | - | - | - | - | - | - | 790 | 73.796 | 961.511 | 287.206 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 6.698 |
| Receivables | - | - | - | - | - | - | 242 | 69.245 | 914.189 | 265.491 |
| Cash | - | - | - | - | - | - | 548 | 4.551 | 47.322 | 15.017 |
| Shareholders Funds | - | - | - | - | - | - | -657 | -5.561 | -49.030 | -252.784 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 161.879 | 403.184 | 2.094.959 | 1.764.487 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6820 - 6820" | |||||||||
| CAEN Financial Year |
6820
|
|||||||||
Comments - Medisprof Cancer Center Moldova S.r.l.